Literature DB >> 22461859

Gene Therapy for Pain: A Perspective.

David J Fink1, Darren Wolfe.   

Abstract

Entities:  

Year:  2011        PMID： 22461859      PMCID： PMC3313471          DOI： 10.2217/pmt.11.49

Source DB:  PubMed          Journal:  Pain Manag        ISSN： 1758-1869


× No keyword cloud information.
  18 in total

1.  Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion.

Authors:  J R Goss; M Mata; W F Goins; H H Wu; J C Glorioso; D J Fink
Journal:  Gene Ther       Date:  2001-04       Impact factor: 5.250

2.  Transgene-mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect in neuropathic pain.

Authors:  Shuanglin Hao; Marina Mata; William Goins; Joseph C Glorioso; David J Fink
Journal:  Pain       Date:  2003-03       Impact factor: 6.961

3.  Adeno-associated viral transfer of opioid receptor gene to primary sensory neurons: a strategy to increase opioid antinociception.

Authors:  Y Xu; Y Gu; G-Y Xu; P Wu; G-W Li; L-Y M Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-28       Impact factor: 11.205

4.  Herpes vector-mediated expression of proenkephalin reduces bone cancer pain.

Authors:  James R Goss; Cara F Harley; Marina Mata; Mark E O'Malley; William F Goins; XiaoPing Hu; Joseph C Glorioso; David J Fink
Journal:  Ann Neurol       Date:  2002-11       Impact factor: 10.422

5.  Attenuation of pain-related behavior in a rat model of trigeminal neuropathic pain by viral-driven enkephalin overproduction in trigeminal ganglion neurons.

Authors:  Alice Meunier; Alban Latrémolière; Annie Mauborgne; Sylvie Bourgoin; Valérie Kayser; François Cesselin; Michel Hamon; Michel Pohl
Journal:  Mol Ther       Date:  2005-04       Impact factor: 11.454

6.  Gene transfer of glutamic acid decarboxylase reduces neuropathic pain.

Authors:  Shuanglin Hao; Marina Mata; Darren Wolfe; Shaohua Huang; Joseph C Glorioso; David J Fink
Journal:  Ann Neurol       Date:  2005-06       Impact factor: 10.422

7.  Gene therapy for pain: results of a phase I clinical trial.

Authors:  David J Fink; James Wechuck; Marina Mata; Joseph C Glorioso; James Goss; David Krisky; Darren Wolfe
Journal:  Ann Neurol       Date:  2011-07-27       Impact factor: 10.422

8.  Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons.

Authors:  J Braz; C Beaufour; A Coutaux; A L Epstein; F Cesselin; M Hamon; M Pohl
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

Review 9.  Gene therapy for the treatment of sensory neuropathy.

Authors:  Marina Mata; Munmun Chattopadhyay; David J Fink
Journal:  Expert Opin Biol Ther       Date:  2006-05       Impact factor: 4.388

10.  TRPV1: a target for next generation analgesics.

Authors:  Louis S Premkumar; Parul Sikand
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363
View more
  4 in total

Review 1.  New and developing drugs for the treatment of neuropathic pain in diabetes.

Authors:  Roy Freeman
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

2.  Gene Transfer of Brain-derived Neurotrophic Factor (BDNF) Prevents Neurodegeneration Triggered by FXN Deficiency.

Authors:  Yurika Katsu-Jiménez; Frida Loría; Juan Carlos Corona; Javier Díaz-Nido
Journal:  Mol Ther       Date:  2016-02-05       Impact factor: 11.454

3.  Grand Challenges in Neuromodulatory Interventions.

Authors:  Julie G Pilitsis
Journal:  Front Pain Res (Lausanne)       Date:  2021-07-02

4.  Soft, stretchable, fully implantable miniaturized optoelectronic systems for wireless optogenetics.

Authors:  Sung Il Park; Daniel S Brenner; Gunchul Shin; Clinton D Morgan; Bryan A Copits; Ha Uk Chung; Melanie Y Pullen; Kyung Nim Noh; Steve Davidson; Soong Ju Oh; Jangyeol Yoon; Kyung-In Jang; Vijay K Samineni; Megan Norman; Jose G Grajales-Reyes; Sherri K Vogt; Saranya S Sundaram; Kellie M Wilson; Jeong Sook Ha; Renxiao Xu; Taisong Pan; Tae-Il Kim; Yonggang Huang; Michael C Montana; Judith P Golden; Michael R Bruchas; Robert W Gereau; John A Rogers
Journal:  Nat Biotechnol       Date:  2015-11-09       Impact factor: 54.908
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.